VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
7 hedge funds and large institutions have $3.8K invested in Viracta Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-25
Holders Change %
-78.13%
% of All Funds
0.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
2
Reduced
–
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
$2.2K |
| 2 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
$283 |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$0 |
| 3 |
ACM
Aisling Capital Management
New York
|
$0 |
| 4 |
Renaissance Technologies
New York
|
$0 |
| 5 |
BlackRock
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OC
26
Oarsman Capital
Milwaukee,
Wisconsin
| – | -$161 | -1,000 | Closed |
|
27
JPMorgan Chase & Co
New York
| – | -$116 | -721 | Closed |
|
|
ITIM
28
Indiana Trust & Investment Management
Mishawaka,
Indiana
| – | -$32 | -200 | Closed |
|
|
SS
29
SBI Securities
Tokyo,
Japan
| – | -$29 | -180 | Closed |
|
30
Wells Fargo
San Francisco,
California
| – | -$28 | -171 | Closed |
|
|
AA
31
Addison Advisors
Middlebury,
Vermont
| – | -$1 | -4 | Closed |
|